Publications by authors named "Henry Gomez"

Claim this Profile
A
Assessment of Adjuvant Endocrine Therapy With Ovarian Function Suppression by Breast Cancer Index.
Ruth M O'Regan, Yue Ren, Yi Zhang, Natalia Siuliukina, Catherine A Schnabel, Henry L Gomez

JAMA Netw Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of HER2 Changes on Survival Outcomes After Neoadjuvant Chemotherapy in Peruvian Patients With Triple-Negative Breast Cancer.
Zaida Morante, Yomali Ferreyra, Iris Otoya, Natalia Valdiviezo, Norma Huarcaya-Chombo, Henry L Gomez

Breast J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decision-Making Patterns for Clinically Node-Positive, Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: Insights From a Survey of Breast Cancer Experts.
Yoonwon Kook, Minji Lee, Seung Ho Baek, Henry Gomez, Soong June Bae

J Breast Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with accepting chemotherapy despite the risk of fertility loss in Latin American breast cancer patients-LACOG 0414 study.
Gustavo Werutsky, Cynthia Villarreal-Garza, Henry L Gomez, Saúl Campos-Gómez, Rosa Ortiz Reyes

Ther Adv Med Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging existing cohort studies of Mexican women to better understand Hispanic health and cancer risk.
Dalia Stern, Liliana Gomez-Flores-Ramos, Britton Trabert, V Wendy Setiawan, Loïc Le Marchand, Henry Gomez

Cancer Causes Control· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOXC1 Expression Predicts Capecitabine Efficacy in Patients with Triple-Negative Breast Cancer from the GEICAM_CIBOMA Trial.
Federico Rojo, Clive R Taylor, Carlos Barrios, Laura Torrecillas, Manuel Ruiz-Borrego, Henry Gomez

Clin Cancer Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Management in BRCA Carriers with Early Breast Cancer.
Bruno Muñante, Roberto Paz-Manrique, Joseph A Pinto, Henry L Gomez

Cancer Control· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stromal tumor infiltrating lymphocytes and TNBC-DX provide complementary prognostic information in triple-negative breast cancer.
Shane R Stecklein, Miguel Martín, Guillermo Villacampa, María Del Monte-Millan, Rachel Yoder

J Natl Cancer Inst· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virtual Reality Interventions of Daily Versus Weekly Data Collection in Patient-Reported Outcomes Among Adults With Cancer: Pilot Survey Study.
Matthew Browning, Olivia McAnirlin, Fu Li, Jeffrey Bertrand, Denise Davis, Teny Henry Gomez

JMIR Form Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Female sex hormones and the oral contraceptive pill modulate asthma severity through GLUT-1.
Alexandra C Brown, Olivia R Carroll, Jemma R Mayall, Nazanin Zounemat-Kermani, Samantha L E Vinzenz, Henry M Gomez

Mucosal Immunol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guideline Utilization in Oncology: Addressing Barriers and Facilitators in Latin America and the Caribbean.
Yanin Chavarri-Guerra, Luis Corrales, James D Morgante, Henry Gomez, Alba Kihn-Alarcón

JCO Glob Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Relevance of Inflammatory Cytokines Il-6 and TNF-Alpha in Patients with Breast Cancer: A Systematic Review and Meta-Analysis.
Jhony A De La Cruz-Vargas, Henry Gómez, Jesus E Talavera, Cristhian Gonzales-Rospigliosi, Ariana Alessandra Córdova Salazar

Curr Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Experience of HER2-Positive Advanced Breast Cancer (ABC) Treatment and Evaluation of Blood Biomarkers in a Public Institution in Latin America (LATAM).
Guillermo Valencia, Patricia Rioja, Olenka Peralta, Miguel Chirito, Raúl Mantilla

Breast Cancer (Auckl)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Situ Detection of Individual Classic MHC-I Gene Products in Cancer.
Paula I Gonzalez-Ericsson, Susan R Opalenik, Violeta Sanchez, Amy M Palubinsky, Ann Hanna, Henry L Gomez

Cancer Immunol Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk and Prognosis of Hepatocellular Carcinoma in Mexican Americans with Type 2 Diabetes Mellitus.
Rikita I Hatia, Lu-Yu Hwang, Ruosha Li, Catherine Troisi, Prasun K Jalal, Henry F Gomez

J Hepatocell Carcinoma· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Atezolizumab for Early Triple-Negative Breast Cancer: The ALEXANDRA/IMpassion030 Randomized Clinical Trial.
Michail Ignatiadis, Andrew Bailey, Heather McArthur, Sarra El-Abed, Evandro de Azambuja, Henry Gomez

JAMA· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoints are suppressed during pregnancy following influenza A virus infection.
Rebecca L Vanders, Henry M Gomez, Katie Daly, Peter A Wark, Jay C Horvat

Am J Physiol Lung Cell Mol Physiol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-Line (1L) Treatment Decision Patterns and Survival of Hormone Receptor (HR)-Positive/HER2-Negative Advanced Breast Cancer (ABC) Patients in a Latin American (LATAM) Public Institution.
Guillermo Valencia, Patricia Rioja, Miguel Chirito, Olenka Peralta, Jorge Sánchez, Henry L Gomez

Curr Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Pertuzumab and Trastuzumab in Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the APHINITY Trial: Third Interim Overall Survival Analysis With Efficacy Update.
Sibylle Loibl, Jacek Jassem, Amir Sonnenblick, Damien Parlier, Eric Winer, Henry L Gomez

J Clin Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A plain language summary of the CAPItello-291 study: Capivasertib in hormone receptor-positive advanced breast cancer.
Nicholas C Turner, Mafalda Oliveira, Sacha J Howell, Florence Dalenc, Javier Cortés, Henry L Gomez

Future Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maternal thirdhand exposure to e-cigarette vapor alters lung and bone marrow immune cell responses in offspring in the absence or presence of influenza infection.
Chantal Donovan, Andrew E Thorpe, Rochelle Yarak, Madison Coward-Smith, Amber L Pillar, Henry M Gomez

Am J Physiol Lung Cell Mol Physiol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact on Survival with Immunotherapy and Evaluation of Biomarkers in Peruvian Patients with Advanced Melanoma.
Guillermo Valencia, Katia Roque, Patricia Rioja, José Andrés Huamán, Valeria Colomo

Onco Targets Ther· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding Comorbidities of Respiratory Models as Novel Platforms for Drug Discovery.
Simone N De Luca, Avanka Gunatilaka, Madison Coward-Smith, Henry M Gomez, Richard Y Kim

ACS Pharmacol Transl Sci· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capivasertib and fulvestrant for patients with hormone receptor-positive, HER2-negative advanced breast cancer (CAPItello-291): patient-reported outcomes from a phase 3, randomised, double-blind, placebo-controlled trial.
Mafalda Oliveira, Hope S Rugo, Sacha J Howell, Florence Dalenc, Javier Cortes, Henry L Gomez

Lancet Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological features associated with CD44 and CD63 expression in breast cancer.
Carlos A Castaneda, Miluska Castillo, Joselyn Sanchez, Luis Bernabe, Katherin Tello, Henry L Gomez

Ecancermedicalscience· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis